GLENMARK PHARMA (GLENMARK) - Live BSE, NSE Stock Quotes - GLENMARK PHARMA Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA   (GLPH)

REFRESH
Live BSE Quotes Jul 29, 2016 (Close)
Price (Rs)860.05 Open (Rs) 853.00 High (Rs) 864.50 Low (Rs) 852.45
% Change0.82 Volume 26,704 Value (Rs) 22,952,957 52-Week H/L 1,261.95 / 671.50
Live NSE Quotes Jul 29, 2016 (Close)
Price (Rs)860.95 Open (Rs) 857.85 High (Rs) 864.75 Low (Rs) 851.25
% Change1.12 Volume 452,246 Value (Rs) 388,774,266 52-Week H/L 1,262.90 / 671.10
Valuation
EPS (Rs)* 26.54 P/E Ratio (x) 32.40 Market Cap (Rs m) 233,314.36 P/BV (x) 7.78
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
GLENMARK PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new

Related Views On News

Glenmark: Margins under Pressure (Quarterly Results Update - Detailed)

Jun 22, 2016

Glenmark has announced its 4QFY16 results. The company has reported 30.5% YoY growth in sales and 1255.8% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Emerging markets disappoint (Quarterly Results Update - Detailed)

Feb 5, 2016

Glenmark has announced its 3QFY16 results. The company has reported 4.5% YoY growth in sales and 48.3% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Good quarter (Quarterly Results Update - Detailed)

Dec 21, 2015

Glenmark has announced its 2QFY16 results. The company has reported 13.4% YoY growth in sales and 19.8% YoY increase in net profits. Here is our analysis of the results.

Lupin: Niche products boost business growth (Quarterly Results Update - Detailed)

Jun 15, 2016

Lupin has announced its 4QFY16 results. Net sales have grown by 38.6% YoY, while net profits declined by 54.8% YoY. Here is our analysis of the results.

Cipla: Impacted by one offs (Quarterly Results Update - Detailed)

Jun 2, 2016

Cipla has announced its 4QFY16 results. The company has reported 7.6% YoY growth in sales and a decline of 68.9% YoY in net profits. Here is our analysis of the results.

More Views on News

Most Popular

Want to Outperform Markets? Test This.(The 5 Minute Wrapup)

Jul 22, 2016

An undercurrent in Indian stock markets that no one has talked about for years!

The Day They Killed the Dollar(Vivek Kaul's Diary)

Jul 16, 2016

They said they had to protect the dollar...

Will Realty Prices Fall Soon?(Chart Of The Day)

Jul 19, 2016

Why real estate prices could fall?

Two Traders Make the Same Trade(Daily Profit Hunter)

Jul 22, 2016

You should check your trades only once per day to maximise your wellbeing. This is a first step in achieving the mindset of a successful trader.

A Little Gem in the FMCG Sector(Sector Info)

Jul 18, 2016

Will investing in Bajaj Corp yield high returns on account of a rural revival in sight?

More

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE GLENMARK PHARMA WITH

MARKET STATS